|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
JPRN |
|
Last refreshed on:
|
17 October 2023 |
|
Main ID: |
JPRN-UMIN000008484 |
|
Date of registration:
|
20/07/2012 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
a
|
|
Scientific title:
|
a - a |
|
Date of first enrolment:
|
2012/07/23 |
|
Target sample size:
|
20 |
|
Recruitment status: |
Pending |
|
URL:
|
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009974 |
|
Study type:
|
Interventional |
|
Study design:
|
Single arm Non-randomized
|
|
Phase:
|
Not selected
|
|
|
Countries of recruitment
|
|
Japan
| | | | | | | |
|
Contacts
|
|
Name:
|
Akira Nomiya |
|
Address:
|
7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan.
Japan |
|
Telephone:
|
03-5800-8753 |
|
Email:
|
|
|
Affiliation:
|
University of Tokyo Department of Urology, Graduate school of medicine |
|
|
Name:
|
Akira Nomiya |
|
Address:
|
7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan.
Japan |
|
Telephone:
|
03-5800-8753 |
|
Email:
|
|
|
Affiliation:
|
University of Tokyo Hosital Department of Urology |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria:
Exclusion criteria: a
Age minimum:
20years-old
Age maximum:
Not applicable
Gender:
Male and Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Interstitial cystitis/ Hypersensitive bladder syndrome
|
|
Intervention(s)
|
|
Administration of mirabegron 50mg per day for four weeks.
|
|
Primary Outcome(s)
|
|
Average voided volume at four weeks of the drug administration.
|
|
Source(s) of Monetary Support
|
|
Department of Urology, Graduate school of medicine, University of Tokyo
|
|
Ethics review
|
Status: YES
Approval date:
Contact:
|
|
Results
|
|
Results available:
|
Yes |
|
Date Posted:
|
|
|
Date Completed:
|
31/03/2013 |
|
URL:
|
|
|
|